Davita-Terre Haute Dialysis Chain: Davita Location: 504 6th Avenue, Terre Haute, Indiana, 47807 Rating: Not Available Phone: (812) 231-8560 |
Davita - Valparaiso Chain: Davita Location: 606 E Lincolnway, Valparaiso, Indiana, 46383 Rating: Phone: (219) 531-1299 |
Davita - Vincennes Dialysis Chain: Davita Location: 700 Willow Street, Ste 101, Vincennes, Indiana, 47591 Rating: Phone: (812) 882-0546 |
Davita - Vincennes Home Dialysis Chain: Davita Location: 700 Willow St Suite 102, Vincennes, Indiana, 47591 Rating: Not Available Phone: (812) 886-9034 |
Fmc-Vincennes Chain: Fresenius Medical Care Location: 300 North 1st, Vincennes, Indiana, 47591 Rating: Not Available Phone: (812) 885-0858 |
FMC - Northeast Indiana Kidney Center-Warsaw Chain: Fresenius Medical Care Location: 3334 Lake City Highway, Warsaw, Indiana, 46580 Rating: Phone: (574) 269-3553 |
Davita - Daviess County Dialysis Chain: Davita Location: 310 Ne 14th Street, Washington, Indiana, 47501 Rating: Phone: (812) 254-9950 |
FMC - Winchester In Chain: Fresenius Medical Care Location: 409 Greenville Avenue, Ste 500, Winchester, Indiana, 47394 Rating: Phone: (765) 584-8000 |
News Archive
A Norwegian study shows that general practitioners in Norway show little competency in understanding different cultures. Researcher Esperanza Diaz at the University of Bergen asks for mandatory training.
ICON plc,, today announced it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.
The Spanish Bioindustry Association (ASEBIO), in collaboration with the Navarre Society of Development (SODENA), and the government of Navarre, will host BioSpain 2010 the biennial international gathering of experts in the biotechnology sector, in Pamplona from September 29th to October 1st. BioSpain 2010 is honoured to welcome three lecturers of international prestige: Mr. Carlos Cordon-Cardo, Vice-Chair of Pathology & Professor, Columbia University; Mr. Larry Fritz, President & CEO, Covella Pharmaceuticals Inc. and Life Science Venture Partner, Westfield Capital Management Company LP; and Mr. Conny Bogentoft, CEO Karolinska Development AB.
HemoShear today announced that it has completed the first phase of development of a novel cancer drug discovery platform that replicates human tumor biology and responds to clinically-relevant drug concentrations.
Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology. Data from the trial demonstrate that the risk for abuse associated with lorcaserin is very low.
› Verified 2 days ago
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. Dialysis facility in medicare covers outpatient maintenance dialysis treatments, training for self-dialysis, self-dialysis support services and self-dialysis equipment and supplies. In some cases, Medicare may cover ambulance transportation when the patient has End-Stage Renal Disease (ESRD), need dialysis, and need ambulance transportation to or from a dialysis facility.
The star rating shows how well a dialysis center delivers care compared to the national average, based on Medicare data. Each dialysis center receives a rating between 1 and 5 stars, with 3 stars representing the national average. A five-star rating means a center has quality of care that is considered 'much above average' compared to other dialysis facilities. A one or two-star rating means that measured health outcomes for that center were below average. The star rating is part of Medicare's work to make data on the quality of patient care easier to understand and use. Patient survey results aren't included in the star rating.